Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17390846 | 0.95 | EPHX2 (0.59) | EPHX2CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL11082223 | 0.90 | CYP1A2 (0.51) | EPHX2CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL8427922 | 0.84 | EPHX2 (0.53) | EPHX2GAAKMT2AHTTSMN1; SMN2 | |
| SCHEMBL2079376 | 0.83 | TSHR (0.50) | EPHX2L3MBTL1HTTSMN1; SMN2TSHR | |
| SCHEMBL17117263 | 0.83 | GAA (0.70) | EPHX2CYP3A4CYP2C19L3MBTL1GAA | |
| SCHEMBL3356126 | 0.82 | SMN1; SMN2 (0.58) | EPHX2L3MBTL1KMT2ASMN1; SMN2TAAR1 | |
| SCHEMBL20818936 | 0.81 | EPHX2 (0.51) | EPHX2CYP3A4CYP2C19L3MBTL1KMT2A | |
| SCHEMBL16620624 | 0.81 | TAAR1 (0.57) | EPHX2L3MBTL1GAAKMT2AHTT | |
| SCHEMBL291194 | 0.81 | SMN1; SMN2 (0.57) | EPHX2HTTSMN1; SMN2HDAC3TSHR | |
| SCHEMBL8247495 | 0.80 | SMN1; SMN2 (0.52) | EPHX2GAAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2986607-B1 | ANTIBACTERIAL BIAROMATIC DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2017-06-14 | — | — | EP | disclosed |
| US-9527867-B2 | Antibacterial biaromatic derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2016-12-27 | — | — | US | disclosed |
| US-9487516-B2 | Antibacterial oxadiazolone derivatives | ACTELION PHARMACEUTICALS, LTD. (CH) | 2016-11-08 | — | — | US | disclosed |
| US-20160075722-A1 | Antibacterial Biaromatic Derivatives | IDORSIA PHARMACEUTICALS LTD (CH) | 2016-03-17 | — | — | US | disclosed |
| EP-2986607-A1 | ANTIBACTERIAL BIAROMATIC DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2016-02-24 | — | — | EP | disclosed |
| US-20150353547-A1 | Antibacterial Oxadiazolone Derivatives | ACTELION PHARMACEUTICALS LTD. (CH) | 2015-12-10 | — | — | US | disclosed |
| EP-2943492-A1 | ANTIBACTERIAL OXADIAZOLONE DERIVATIVES | Actelion Pharmaceuticals Ltd. (CH) | 2015-11-18 | — | — | EP | disclosed |
| WO-2014170821-A1 | ANTIBACTERIAL BIAROMATIC DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2014-10-23 | — | — | WO | disclosed |
| WO-2014108836-A1 | ANTIBACTERIAL OXADIAZOLONE DERIVATIVES | ACTELION PHARMACEUTICALS LTD (CH) | 2014-07-17 | — | — | WO | disclosed |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | disclosed |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | CANO IVAN COLLADO | 2009-03-05 | — | — | US | disclosed |
| CN-101128413-A | Substituted oxyarenes | BAYER CROPSCIENCE AG (DE) | 2008-02-20 | — | — | CN | disclosed |
| EP-1335908-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | LILLY CO ELI (US) | 2008-02-13 | — | — | EP | disclosed |
| US-7304062-B2 | Peroxisome proliferator activated receptor alpha agonists | ELI LILLY AND COMPANY (US) | 2007-12-04 | — | — | US | disclosed |
| US-7304062-B2 | Peroxisome proliferator activated receptor alpha agonists | ELI LILLY AND COMPANY (US) | 2007-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160075722-A1 | Antibacterial Biaromatic Derivatives | CYC1, C5, CYCS | EPHX2 2617/4885CYP1A2 644/4885CYP3A4 285/4885 |
| US-20150353547-A1 | Antibacterial Oxadiazolone Derivatives | OXA1L, PYM1, XDH | EPHX2 2830/4885CYP1A2 681/4885CYP3A4 712/4885 |
| US-20090062358-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS | PPARG, PPARA, PPARD | EPHX2 210/4885CYP1A2 452/4885CYP3A4 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.